CING Q1 2026 Net Loss $9.3M, Cash $25.9M, R&D $2.2M, G&A $5.7M
Cingulate Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.60
+8.9% in 7d after detection
Post-detection moves
1h
—
1d
+4.1%
3d
0.0%
7d
+8.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS